Functionally active A and B chains were separated from a twochain form of recombinant tissue-type plasminogen activator after mild reduction and alkylation. The A chain was found to be responsible for the binding to lysine-Sepharose or fibrin and the B chain contained the catalytic activity of tissue-type plasminogen activator. An extensive reduction of two-chain tissue-type plasminogen activator, however, destroyed both the binding and catalytic activities. A thermolytic fragment, Fr.
Introduction
Plasmin is the sole enzyme responsible for the resolution of thrombi in mammals. Plasmin circulates in blood in its zymogen form, plasminogen. It is converted to plasmin by tissue-type plasminogen activator (tPA).' tPA is synthesized in endothelial cells (1, 2) and released into plasma by various stimuli (3) . A trace amount of tPA is found in blood (3, 4) . The fibrinolytic activity is, however, detectable in plasma only after fibrin clots are formed (5, 6 ). This phenomenon is in accord with the finding that the enzyme activity of tPA is greatly enhanced, when it hydrolyzes plasminogen in the presence of fibrin (7, 8) .
The enhancement of fibrinolytic activity of tPA is apparently due to the conformational changes of tPA within a complex with plasminogen and fibrin (8) . Both plasminogen and tPA have binding affinity to fibrin (9, 10) . The binding property of plasminogen to fibrin has been characterized. Lysine or e-amino caproic acid (EACA) binds to plasminogen in a region that contains the first three kringles (kringle 1-3) and competitively inhibits the binding of plasminogen to fibrin (10) (11) (12) . Therefore, fibrin and these amino acids presumably share a common binding site on the plasminogen molecule (13) . Lerch et al. isolated 1 . Abbreviations used in this paper: EACA, e-amino caproic acid; IAA, iodoacetoamide; TB, 50 mM Tris-HCI buffer, pH 7.5; tPA, tissue-type plasminogen activator. the kringle-1 segment from plasminogen and demonstrated that this segment had a high binding affinity with EACA (14) . Recently, two Arg residues in kringle-1 of plasminogen have been found to be involved in the binding to fibrin (15) . tPA has been shown to bind to fibrin-Sepharose and to be eluted by a buffer containing lysine (16) . This chromatographic behavior indicates that tPA also contains a common binding site to lysine and fibrin. The location ofthe binding site of tPA to fibrin, however, has not been studied.
tPA is synthesized as a single-chain precursor (17) and is proteolytically activated in vitro into a two-chain form by plasmin (17, 18) , tissue kallikrein and activated Factor X (19) . Twochain tPA consists of an A and a B chain that are connected by an interchain disulfide bond. The complete amino acid and cDNA sequences of tPA have been determined (20) (21) (22) and revealed that tPA contained in the A chain a region that comprised two consecutive kringle segments. This region is structurally analogous to the kringle 1-3 fragment in plasminogen (23) and could be a binding site oftPA to fibrin. In addition to the kringles, the A chain has one type I segment that was found in fibronectin and one growth factor segment at the amino terminal portion, while the structure of the B chain is typical of serine proteases.
In this communication, we report that the binding site of tPA to lysine-Sepharose or fibrin is located in its kringle-2 segment.
Methods
A two-chain form ofrecombinant tPA was a gift from Dr. Gordon Vehar of Genentech, South San Francisco, CA. Thermolysin was purchased from Calbiochem, La Jolla, CA. The peptide substrate (S-2322) was a gift from Kabi Peptide Research, Molndal, Sweden. Lysine-Sepharose was prepared according to the published method (24) .
tPA was radiolabeled with '25I-Na (Amersham Corp., Arlington Heights, IL) using Enzymobeads (Bio-Rad Laboratories, Richmond, CA). To remove inactivated molecular species oftPA that were formed during iodination, 1251I-tPA was adsorbed on a lysine-Sepharose column equilibrated with Tris-buffered (TB)-Tween containing 0. (18, 28) . These two chains are linked by one interchain disulfide bond (21) . To localize the binding region of tPA to fibrin or the antifibrinolytic amino acids, lysine and EACA, separation of active A and B chains of tPA was attempted with affinity chromatography on lysine-Sepharose column after mild reduction of two-chain tPA. For this experiment, the conditions of van der Graafet al. (29), which were developed for the separation of the functionally active heavy and light chains of plasma kallikrein, applied with some modifications.
Two-chain 1251-tPA was incubated with several concentrations of DTT and the degree of reduction was determined by applying an aliquot of the samples to the lysine-Sepharose column. All of the 1251-tPA adsorbed to the column if the reducing reagent was not present in the reaction. The radioactivity in the nonadsorbed fraction increased in parallel with the increasing concentration of DTT. 43% of radioactivity passed through the column in the presence of 2.5 mM DTT and 62% of '251-tPA passed through the column at 5 mM DTT. More than 98% of tPA was found in the pass-through fraction at 100 mM DTT.
These data suggested that the lowest concentration of DTT required for the complete reduction of the interchain disulfide bond of two-chain tPA was around 5 mM.
A larger amount oftwo-chain tPA (200 ,g) was reduced and alkylated as described in Methods. The sample was then applied to the lysine-Sepharose column. Adsorbed protein was eluted with the buffer containing 1 M EACA. Based on the absorbance at 280 nm, -70% of the protein passed through the column and the remaining 30% was recovered in the eluate (Fig. 1 ). Both protein fractions were concentrated and subjected to SDS-polyacrylamide slab gel electrophoresis. Protein from the unadsorbed fraction gave a band of an approximate molecular mass of 32 kD and the protein eluted with 1 M EACA showed a characteristic doublet band corresponding to molecular mass of 35 and 32 kD, indicating that the unadsorbed fraction contained the B chain and the eluate contained the A chain.
The separated A and B chains of tPA were also analyzed by reverse-phase HPLC to establish their homogeneity. Two-chain tPA eluted in a single peak from an Altex C3 column at 21 min (Fig. 2, I ), while the reduced and alkylated tPA separated into two distinct peaks eluted at 19 and 22 min, respectively (Fig. 2,  II) . The materials in the unadsorbed fraction (B chain) and the EACA eluate (A chain) from the lysine-Sepharose column emerged as single symmetrical peaks at exactly the same positions as those obtained with reduced and alkylated two-chain tPA (Fig. 2, III and IV) , showing that the alkylated A and B chains were homogeneous. Table I shows the amidolytic activity before and after the separation ofthe A and B chains by the lysine-Sepharose column. tPA was slightly denatured after reduction with 5 mM DTT resulting in a 72% recovery of the amidolytic activity. 65% of the original activity was recovered in the unadsorbed fraction (B chain). The specific activity ofthe separated B chain was 15% lower than intact two-chain tPA. A trace of the enzyme activity (3%) was found in the eluate (A chain).
These results clarified that the binding site of tPA to the antifibrinolytic amino acids or fibrin was located in the A chain and the B chain contained the catalytic activity.
Localization oflysine binding site oftPA. Limited proteolysis of two-chain tPA with several enzymes (trypsin, chymotrypsin, tissue kallikrein, plasmin, elastase, Staphylococcus aureus V8 protease, lysyl-endopeptidase and thermolysin) was conducted to localize the binding site in the A chain of tPA. Of these enzymes, digestion with thermolysin gave the most promising All samples were dialyzed against TB-Tween containing 0.3 M NaCI before assay. Amidolytic activities were assayed using Val-Gly-Arg-p-nitroanilide (S-2322) as previously described (19) . * The fractions 4-9 and 23-28 from the lysine-Sepharose column ( Fig. 1) were separately pooled. fragmentation. Two-chain tPA (300 ,g, 4 nmol) was digested with thermolysin (10 Mg). During the digestion, small aliquots were taken at various times and analyzed by reverse-phase HPLC using the Altex column. At zero time, the starting two-chain tPA eluted as a single peak from the column (Fig. 3 A, I ). At 20 h, 50% of tPA was degraded and produced a major fragment, Fr. 1, along with several minor fragments (Fig. 3 A, II) . Further digestion for 44 h generated another major fragment, Fr. 2 ( Fig.   3 A, III). The Fr. 2 peak increased at 68 h with a concomitant decrease ofthe Fr. 1 peak (Fig. 3 A, IVand Fig. 3 (Fig. 3 B, VI) and all other peaks, including Fr. 2, that were present in the 68-h digest were found in the unadsorbed fractions (Fig. 3 B Without alkylation of the samples, half cystinyl residues were not detectable and the presence of half cystinyl residues in the fragments were assigned by the published sequence (21) . By comparing with the established tPA sequence, three sequences were found to satisfy the analysis of Fr. 1: the first started with Val 48 to Thr 61 in the growth factor segment, the second from Phe 71 to Glu 85 also in the growth factor segment, the third was a heptapeptide, Val 394 to Asp 400 from the B chain. The structure of Fr. 1 thus was found to consist of a growth factor segment that was cleaved between the Asp 70 and Phe 71 bond, and two intact kringles followed by a part of the connecting region to which a heptapeptide ofthe B chain was connected by a disulfide bond (Fig. 4, left) .
The molecular mass of Fr. 1 was found to be -29 kD in the absence of reducing agent (Fig. 5, B) . This value is in good agreement with the molecular mass calculated from the composition ofthe structure shown in Fig. 4 . This structure contains 235 amino acid residues and two Asn-linked carbohydrate chains at 107 and 184. In the presence ofreducing agent, the molecular mass of Fr. 1 was found to be -26 kD (Fig. 5, E) . The decrease of the molecular weight of Fr. 1 under reducing condition is accounted for by the removal of a half of the growth factor and a heptapeptide. At present, it is not known whether all of the residues Gln 63-Asp 70 in the growth factor segment and the carboxyl-terminal 11 residues Gly 265-Arg 275 that follows the kringle-2 segment are contained in Fr. 1 or not.
Similarly, sequence of Fr. 2 was analyzed for 10 cycles and four major sequences were found in this fragment (Table II) . The (Fig. 4, right) . There (Fig. 5, C) . Con- The Cys residues were assigned from the published sequence of tPA (21) . The sequences that were marked by -at their ends continue further and the sequences that were not marked terminate as they are shown. (Fig. 5, F) . This molecular mass agrees with that calculated from the composition of the largest fragment, Phe 71 to Cys 201. This fragment contains 140 amino acid residues and one carbohydrate chain, and consists of the kringle-1, one-half of growth factor and one quarter of the kringle-2 segments. This result also indicates that the kringle-1 segment in Fr. 2 is intact. The loss of binding ability of Fr. 1 thus was probably caused by the removal ofthe peptide segment from kringle-2.
Discussion
A striking feature of tPA is that its enzyme activity is enhanced 1,000-fold when the molecule binds to fibrin clots (7, 8 kallikrein (29), and Factor XIa (33). The treatment of two-chain tPA with 5 mM DTT reduced the interchain disulfide bond without affecting the functional activities of both chains. The behavior ofthe isolated A chain to the lysine-Sepharose column was similar to the intact two-chain tPA molecule; it adsorbed to the column and was retained until the column was eluted with the buffer containing 1 M EACA. The specific amidolytic activity of the separated B chain was 85% of the intact twochain tPA. Digestion of the elastase fragment of plasminogen with chymotrypsin produced the intact kringle-l segment, which was found to be the binding site of plasminogen to lysine or fibrin (14, 15 (37) .
In our preliminary experiments, radiolabeled Factor XII and prothrombin did not bind to fibrin (unpublished data). These facts indicate that the presence of the kringle segment is not enough to provide the molecules the binding affinity to fibrin.
The present result showed a possibility that a peptide region between Leu 202 and Gly 225 could be the binding site to fibrin. It is interesting to note that the amino acid sequences of this region are variable among the kringle segments of the different proteins. The binding affinity is possibly determined by the amino acid sequence in this region. This may explain why tPA and plasminogen have affinity to fibrin while the others do not. The extensive reduction of two-chain tPA gave rise to the complete loss of its binding ability. It is thus postulated that the amino acid sequence in the variable region in the correctly folded kringle-2 structure is essential for the binding of tPA to fibrin.
Our experiments found that the binding affinity of tPA to fibrin was much stronger than that of plasminogen. A 50% inhibition of the binding of tPA to fibrin was observed in the presence of 10 mM EACA (38) Kringle-2 for tPA to become bound to fibrin clots after it is released from endothelial cells into blood (1) (2) (3) , where a large excess of plasminogen circulates. The concentrations of plasminogen (39) and tPA (3, 40) in blood were reported at 2 ,uM and 0.1 nM, respectively. It was reported (41) that 80% of tPA adsorbed to fibrin at the physiological concentration (3 mg/ml).
At present, comparative binding parameters for Fr. 1 with the parent molecule, two-chain tPA, are not available. In the case ofplasminogen, the binding affinity ofkringle 1-3 was found to be substantially weaker than its parent molecule (10) . Accordingly, it is probable that the other segments such as type I, growth factor, and kringle-I of tPA also contribute to the maximum binding activity of tPA.
